GLOBAL PATIENT SAFETY CHALLENGE: USE OF TECHNOLOGY EDGE BED WITH DATA MATRIX IN ANTICANCER ORAL ADMINISTRATION

Introduction: Medication errors with antineoplastic agents have been the subject of publications in several countries and the use of oral anticancer pharmaceutical industry increased over the last 5 years. Based on voluntary notifications in the FDA’s Adverse Event Reporting System errors with antineoplastic corresponded to the second most common cause of fatal errors related to medications. Publish on security tools and methods to minimize this damage is of extreme importance as social responsibility and ethics. ¹, ² according to the NCCN-National Comprehensive Cancer Network, the use of oral anticancer agents affect all aspects in oncological patient care, including the establishment of security and membership. ³ The use of technology edge bed with data Matrix in anticancer oral administration, enables your screening since the separation, distribution and checking This technology ensures the correct medication at the correct patient (via the bracelet): only after the screening and correct check the nurse administers the antineoplastic and digitally signs with the barcode of your badge. Objective: to present the results of the use of technology edge bed with data matrix in anticancer oral administration. Method: this is a descriptive and quantitative study conducted in large private hospital specializing in Oncology in the city of São Paulo. Conducted survey of data from medical records of patients diagnosed with cancer and in use of oral antineoplastics in October 2018 to may 2019, with the medicines dispensed by the pharmacy or brought by the patient and validated by the Clinical pharmacist. The data were collected: drugs, drug classification, diagnosis and percentage (%) edge checking bed using data matrix technology. Exclusion criteria: patient records that are not included in the information for research. Results: 1742 administrations were analyzed oral antineoplastics being 1253 checked with edge technology, averaging 72%. Conclusion: the tool edge bed management brings security in the administration of antineoplastic. The data obtained from 72% is considered positive for bringing a new scenario for the management and monitoring of eight months that bookmark, we had an increase in the membership of the process over the months and in the last month may 2019 reached 85%. As action plan, this indicator will be monitored every two weeks for identification of process failures and improving management in our healthcare practice.